Abstract
High-dose propofol infusion for sedation of patients in the intensive care unit can result in rhabdomyolysis, acute renal failure, metabolic acidosis, hyperkalemia, ventricular arrhythmia, hyperthermia, and death. The death of a patient with such complications after lung biopsy is reported. Until a safer dosage range has been determined, propofol infusion at rates higher than 5 mg x kg(-1) x h(-1) should be discouraged for long-term sedation (> 48 h).
MeSH terms
-
Acidosis / chemically induced
-
Acute Kidney Injury / chemically induced
-
Adult
-
Anesthetics, Intravenous / adverse effects*
-
Creatine Kinase / blood
-
Dose-Response Relationship, Drug
-
Electrocardiography
-
Fatal Outcome
-
Humans
-
Hyperplasia
-
Intubation, Intratracheal
-
Lung / pathology
-
Lung / surgery
-
Lung Neoplasms / surgery*
-
Male
-
Multiple Organ Failure / chemically induced
-
Propofol / adverse effects*
-
Pulmonary Alveoli / pathology
-
Respiratory Distress Syndrome / complications
-
Respiratory Distress Syndrome / therapy
-
Rhabdomyolysis / chemically induced
-
Smoking / adverse effects
-
Tachycardia, Ventricular / chemically induced
-
Ventricular Fibrillation / chemically induced
Substances
-
Anesthetics, Intravenous
-
Creatine Kinase
-
Propofol